Ads
-
Related paper
- Evaluation of Metabolic Disorders in Patients with Arterial Hypertension in Combination with Obesity on Nesfatin-1 Level
- Evaluation of metabolic disorders and aging rates depending on SIRT1 polymorphism in patients with arterial hypertension and subclinical hypothyroidism
- Clinical-Haemodynamic and Metabolic Effects of Dietary Therapy in Patients with Arterial Hypertension and Obesity
- CLINICAL AND DIAGNOSTIC VALUE OF ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTEIAL HYPERTENSION IN COMBINATION WITH GOUT AND OBESITY
- The Relationship between the Degree of Obesity, Metabolic Disorders of Uric Acid and Lipid Metabolism in Patients with Hypertension and Gout
- Serum Chemerin and Nesfatin-1 Levels and Peculiarities of Clinical Characteristics in Patients with Hypertension and Obesity
- Features of Сlinical-metabolic Disorders and Structural-functional Changes of Heart in Patients with Essential Hypertension with Abdominal Obesity and Heart Hypertrophy
- IMPACT OF METABOLIC CHANGES ON THE DEVELOPMENT OF ARTERIAL HYPERTENSION IN CHILDREN WITH OVERWEIGHT AND OBESITY
- Evaluation of the state of medical care in patients with arterial hypertension in combination with gout by retrospective analysis data
- SPECIFIC CONTRIBUTION OF NEURAL AND HUMORAL MECHANISMS TO THE DEVELOPMENT OF ARTERIAL HYPERTENSION OF DIFFERENT ORIGIN: UNDER METABOLIC OBESITY AND ALCOHOL ADDICTION IN RATS